Skip to Content

Drug Pricing Letters, Comments, & Resources

Comments on Centers for Medicare and Medicaid Services Drug Price Negotiation Program (6/20/23)

Comments on FSS Pricing Disclosures and Sales Reporting (10/30/19)

Back to top